Cellectar Biosciences shares dip on $10.7M securities offering
seekingalpha.com
finance
2022-10-21 13:02:02

Cellectar Biosciences (NASDAQ:CLRB) shares fell ~18% premarket on announcing concurrent registered direct and private placement offerings of ~$10.7M priced at-the-market under Nasdaq rules The company has entered into definitive agreements with several institutional investors for the purchase of 3,275,153 shares at $2.085/share in a registered direct offering and warrants to purchase up to an aggregate of 3,275,153 shares of common stock in a concurrent private placement priced at-the-market. In a separate concurrent private placement transaction, the company has agreed to sell pre-funded warrants to purchase up to an aggregate of 1,875,945 shares of common stock and warrants to purchase up to an aggregate of 1,875,945 shares of common stock.
